Catheter Precision, Inc.
VTAK
$0.30
-$0.0262-8.03%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.57% | -4.98% | 27.07% | 140.88% | 387.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.57% | -4.98% | 27.07% | 140.88% | 387.78% |
| Cost of Revenue | 92.00% | 40.00% | 65.22% | 100.00% | -67.11% |
| Gross Profit | 4.59% | -8.25% | 24.05% | 145.12% | 2,857.14% |
| SG&A Expenses | 27.59% | -33.72% | -50.87% | -53.10% | -60.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.66% | -33.83% | -51.39% | -54.51% | -64.56% |
| Operating Income | -28.50% | 34.58% | 52.47% | 55.97% | 66.03% |
| Income Before Tax | -127.78% | 80.87% | 85.03% | 88.27% | 92.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -163.08% | 76.42% | 85.03% | 88.27% | 92.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -163.08% | 76.42% | 85.03% | 88.27% | 92.20% |
| EBIT | -28.50% | 34.58% | 52.47% | 55.97% | 66.03% |
| EBITDA | -45.01% | 33.48% | 55.96% | 60.48% | 73.57% |
| EPS Basic | 12.06% | 95.14% | 95.82% | 96.09% | 97.75% |
| Normalized Basic EPS | -543.48% | 67.78% | 83.24% | 88.03% | 99.33% |
| EPS Diluted | 12.06% | 95.14% | 95.82% | 96.09% | 97.75% |
| Normalized Diluted EPS | -543.48% | 67.78% | 83.24% | 88.03% | 99.33% |
| Average Basic Shares Outstanding | 785.39% | 494.67% | 149.91% | 155.01% | 303.97% |
| Average Diluted Shares Outstanding | 785.39% | 494.67% | 149.91% | 155.01% | 303.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |